Immuno-Oncology Biomarkers: Today’s Imperatives for Tomorrow’s Needs Schedule

Wednesday, Nov. 8

8 – 8:15 a.m.

Welcome and Introductions
Lisa H. Butterfield, PhD – UPMC Hillman Cancer Center

Session I: Biomarkers in Development

8:15 – 8:25 a.m. Presentation 1
8:25 – 8:35 a.m. Presentation 2
8:35 – 8:45 a.m. Presentation 3
8:45 – 8:55 a.m. Presentation 4
8:55 – 9:10 a.m. Group Discussion
9:10 – 9:20 a.m. Presentation 5
9:20 – 9:30 a.m. Presentation 6
9:30 – 9:40 a.m. Presentation 7
9:40 – 9:50 a.m. Presentation 8
9:50 – 10:05 a.m. Group Discussion
10:05 – 10:20 a.m. Break
10:20 – 10:30 a.m. Presentation 9
10:30 – 10:40 a.m. Presentation 10
10:40 – 10:50 a.m. Presentation 11
10:50 – 11 a.m. Presentation 12
11 – 11:15 a.m. Group Discussion
11:15 – 11:30 a.m. Break

Session II: Strategic Considerations of Biomarkers

11:30 – 11:45 a.m. Regulatory Persepective
Gideon Blumenthal, MD Food & Drug Administration
11:45 – 12:25 p.m.

Panel Discussion
Jérôme Galon, PhD – INSERM- Cordeliers Research Center
Francesco Marincola, MD – AbbVie Inc.
Minkyung Song, PhD – National Cancer Institute, NIH

12:25 – 12:30 p.m. Closing Remarks